Scientific Advisory Board Michael A. Chirigos, Ph.D., D.Sc. Former Chief, Laboratory of Immunopharmacology, Division of Cancer Treatment, National Cancer Institute, N.I.H.; Deputy of Science, United States Army Medical Research Institute of Infectious Diseases. Evan M. Hersh, M.D. Vice-Chairman, Department of Internal Medicine; Chief, Section of Hematology and Oncology, Department of Internal Medicine; Director of Clinical Research, Arizona Cancer Center, Tucson, Arizona. Michael J. Mastrangelo, M.D. Director, Division of Medical Oncology, Jefferson Medical College, Philadelphia, PA.; Professor of Medicine, Jefferson Medical College, Philadelphia, PA.; Associate Clinical Director, Jefferson Cancer Center, Philadelphia, PA. Alan G. Morris, Ph.D. Department of Biological Sciences, University of Warwick, Coventry, UK. Board of Directors Maximilian de Clara Chairman and President CEL-SCI Corporation Geert R. Kersten Chief Executive Officer CEL-SCI Corporation F. Donald Hudson Biotechnology Consultant Founder of Several Biotechnology Companies Mark V. Soresi President REMAC USA. Inc. Corporate Officers Maximilian de Clara Chairman of the Board President Geert R. Kersten Chief Executive Officer Treasurer and Secretary Patricia B. Prichep Vice President of Operations Prem Sarin, Ph.D. Vice President of Research, Infectious Diseases Eyal Talor, Ph.D. Vice President of Research and Manufacturing M. Douglas Winship Vice President of Regulatory Affairs and Quality Assurance Daniel Zimmerman, Ph. D. Vice President of Research, Cellular Immunology |